Skip to main content

Tuning the Brain

Deep-brain stimulation is allowing neurosurgeons to adjust the neural activity in specific brain regions to treat thousands of patients with myriad neurological disorders.

Written byAndres Lozano
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00

DEEP-BRAIN STIMULATION (DBS): Electrodes implanted into targeted brain regions deliver electrical stimulation to either excite or inhibit activity in a neural circuit of interest. DBS patients are also fitted with battery-powered implanted pulse generators, typically placed subcutaneously below the clavicle and connected to the electrodes via insulated wires. These pulse generators can deliver electrical stimulation from 20 to 200 times per second. © THOM GRAVESThe world’s first neurosurgeries took place about 7,000 years ago in South America with the boring of holes into hapless patients’ skulls, a process known as trephination. Practitioners of the day believed the source of neurologic and psychiatric disease to be evil spirits inhabiting the brain, and the way to treat such disorders, they reasoned, was to make holes in the skull and let the evil spirits escape. The procedure was surprisingly common, with as many as 1 percent of skulls at some archaeological sites having these holes.

Today, neurosurgeons are still drilling into the brains of patients suffering from neurologic and psychiatric disorders, but rather than letting evil spirits escape, doctors are putting things in—inserting electrical probes to tame rogue neurons or to stimulate brain regions that are underperforming. This procedure, known as deep-brain stimulation (DBS), was first tried for the treatment of pain in the 1960s, and has since been attempted in patients with numerous other neurologic disorders. DBS is currently approved in the U.S. or Europe for the treatment of essential tremor, Parkinson’s disease, dystonia (a motor disorder that causes extreme twisting and repetitive motions), epilepsy, and obsessive-compulsive disorder (OCD). The therapy is currently in clinical trials for depression, Alzheimer’s disease, addiction, and more.

Each of these disorders is a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Published In

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo